New protein identified in bacterial arsenal

Mar 03, 2009
New protein identified in bacterial arsenal
Top feeder. Ubiquitin ligase proteins (green), produced by Salmonella bacteria, are drawn to the surface of the host cells that they infect, near structures called microvilli (red) that help the cells absorb nutrients, among other things.

(PhysOrg.com) -- Nearly a billion years ago, bacteria evolved an insidious means of infecting their hosts — a syringe-like mechanism able to inject cells with stealthy hijacker molecules. These molecules, called virulence factors, play a sophisticated game of mimicry, imitating many of the cells’ normal activities but ultimately co-opting them to serve the bacteria’s needs. Now researchers at The Rockefeller University have identified a new class of these coup artists that appear to take over a key process that regulates a wide range of cellular duties, from cell-cycle progression to cell death, even communication between cells.

Scientists in C. Erec Stebbins’s Laboratory of Structural Microbiology have discovered the crystal structure of virulence factor SspH2, which is deployed by Salmonella, a mean strain of bacteria that can cause food poisoning, typhoid fever and septicemia. With colleagues at Yale University, they performed a series of biochemical experiments to show that SspH2 is an enzyme that links two molecules together, called a ligase. Specifically, it is involved in the targeting of a widespread regulatory molecule called ubiquitin to other proteins. Ubiquitin’s most common function is to label proteins for degradation in a process called ubiquitination.

“It’s a totally new ubiquitin ligase from a bacterial pathogen going in and messing around with human cell chemistry,” says Stebbins. “It’s a good example of the amazing ways bacteria have found to play around with our biochemistry for its own purposes.”

The structure, derived from the pattern of light bouncing off of a crystallized form of SspH2, reveals the identity and position of every atom in the virulence factor. It shows that it has two primary arms: One is a known structure that recruits other proteins, but the second had never been seen before. The Stebbins team named it NEL for Novel E3 Ligase. The two arms conceal a key amino acid — cysteine — required to bind to ubiquitin. In test-tube experiments, Stebbins and colleagues showed that in order to capture the ubiquitin, one arm must swing apart to expose the cysteine, and moreover, it must do so in a selective fashion. They generated a version of the molecule effectively locked in its open state and found that it was toxic to the cells it invaded.

The process of attaching ubiquitin to targeted proteins — ubiquitination — is very common in the cells of complex organisms and involves three different types of molecules such as SspH2. Molecules known as E1 capture the ubiquitin and hand it off to E2 molecules. E3 molecules then bring the E2 and its ubiquitin to attach to specific proteins. Stebbins and colleagues determined that SspH2 is a new member of this third family and that it targets proteins on top of cell membranes, but exactly which ones remain to be seen.

“When we find that out, we’ll know exactly what this ubiquitin ligase is doing,” Stebbins says. The findings are published this week in the Proceedings of the National Academy of Sciences.

More information: Proceedings of the National Academy of Sciences online, A family of Salmonella virulence factors functions as a distinct class of E3 ubiquitin ligases, Cindy M. Quezada, Stuart W. Hicks, Jorge E. Galán and C. Erec Stebbins

Provided by Rockefeller University

Explore further: A new synthetic amino acid for an emerging class of drugs

add to favorites email to friend print save as pdf

Related Stories

Researchers film protein quake for the first time

Aug 27, 2014

One of nature's mysteries is how plants survive impact by the huge amounts of energy contained in the sun's rays, while using this energy for photosynthesis. The hypothesis is that the light-absorbing proteins ...

Introducing the multi-tasking nanoparticle

Aug 26, 2014

Kit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose and treat cancer. Built on an easy-to-make polymer, these particles ...

Recommended for you

Scientists make diseased cells synthesize their own drug

7 minutes ago

In a new study that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have adapted a chemical approach to turn diseased cells into unique manufacturing ...

A new synthetic amino acid for an emerging class of drugs

Aug 31, 2014

Swiss scientists have developed a new amino acid that can be used to modify the 3-D structure of therapeutic peptides. Insertion of the amino acid into bioactive peptides enhanced their binding affinity up to 40-fold. Peptides ...

User comments : 0